ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/25 | 2,941 | 3,085 | 2,898 | 2,980 | +63 | +2.2% | 1,816,400 |
2018/01/24 | 3,065 | 3,150 | 2,850 | 2,917 | -88 | -2.9% | 2,227,600 |
2018/01/23 | 3,055 | 3,250 | 2,958 | 3,005 | -135 | -4.3% | 2,976,600 |
2018/01/22 | 2,899 | 3,320 | 2,899 | 3,140 | +251 | +8.7% | 5,400,100 |
2018/01/19 | 2,652 | 2,889 | 2,610 | 2,889 | +278 | +10.6% | 3,283,500 |
2018/01/18 | 2,550 | 2,675 | 2,455 | 2,611 | ±0 | ±0% | 3,025,500 |
2018/01/17 | 2,670 | 2,843 | 2,580 | 2,611 | -127 | -4.6% | 2,523,000 |
2018/01/16 | 2,901 | 2,950 | 2,672 | 2,738 | -247 | -8.3% | 3,349,500 |
2018/01/15 | 3,050 | 3,100 | 2,933 | 2,985 | -65 | -2.1% | 3,220,100 |
2018/01/12 | 2,850 | 3,170 | 2,783 | 3,050 | +383 | +14.4% | 8,531,500 |
2018/01/11 | 2,555 | 2,710 | 2,552 | 2,667 | +56 | +2.1% | 3,399,100 |
2018/01/10 | 2,646 | 2,752 | 2,544 | 2,611 | -110 | -4% | 3,582,400 |
2018/01/09 | 2,791 | 2,890 | 2,640 | 2,721 | +180 | +7.1% | 7,226,700 |
2018/01/05 | 2,340 | 2,629 | 2,300 | 2,541 | +299 | +13.3% | 12,668,900 |
2018/01/04 | 2,550 | 2,819 | 2,201 | 2,242 | -108 | -4.6% | 12,862,500 |
2017/12/29 | 2,158 | 2,350 | 2,153 | 2,350 | +400 | +20.5% | 9,180,400 |
2017/12/28 | 1,838 | 1,988 | 1,800 | 1,950 | +149 | +8.3% | 6,474,100 |
2017/12/27 | 1,681 | 1,895 | 1,680 | 1,801 | +110 | +6.5% | 8,559,200 |
2017/12/26 | 1,726 | 1,932 | 1,660 | 1,691 | +134 | +8.6% | 12,759,600 |
2017/12/25 | 1,547 | 1,612 | 1,512 | 1,557 | -29 | -1.8% | 2,976,300 |
2017/12/22 | 1,600 | 1,749 | 1,550 | 1,586 | -14 | -0.9% | 12,142,900 |
2017/12/21 | 1,738 | 1,755 | 1,572 | 1,600 | -58 | -3.5% | 17,174,100 |
2017/12/20 | 1,400 | 1,658 | 1,371 | 1,658 | +300 | +22.1% | 9,777,300 |
2017/12/19 | 1,461 | 1,500 | 1,338 | 1,358 | -173 | -11.3% | 7,464,100 |
2017/12/18 | 1,400 | 1,608 | 1,373 | 1,531 | +210 | +15.9% | 21,226,300 |
2017/12/15 | 1,021 | 1,321 | 1,003 | 1,321 | +300 | +29.4% | 22,406,100 |
2017/12/14 | 1,002 | 1,021 | 997 | 1,021 | +21 | +2.1% | 494,500 |
2017/12/13 | 1,021 | 1,026 | 994 | 1,000 | -24 | -2.3% | 648,300 |
2017/12/12 | 1,030 | 1,055 | 1,005 | 1,024 | -23 | -2.2% | 573,800 |
2017/12/11 | 1,009 | 1,050 | 1,009 | 1,047 | +36 | +3.6% | 487,600 |
2017/12/08 | 990 | 1,031 | 987 | 1,011 | +16 | +1.6% | 451,000 |
2017/12/07 | 962 | 1,009 | 962 | 995 | +28 | +2.9% | 600,100 |
2017/12/06 | 996 | 1,010 | 963 | 967 | -33 | -3.3% | 1,037,300 |
2017/12/05 | 1,040 | 1,059 | 995 | 1,000 | -48 | -4.6% | 1,259,500 |
2017/12/04 | 1,084 | 1,090 | 1,040 | 1,048 | -37 | -3.4% | 955,100 |
2017/12/01 | 1,103 | 1,105 | 1,077 | 1,085 | -9 | -0.8% | 381,900 |
2017/11/30 | 1,120 | 1,134 | 1,077 | 1,094 | -25 | -2.2% | 639,500 |
2017/11/29 | 1,111 | 1,132 | 1,107 | 1,119 | +10 | +0.9% | 462,300 |
2017/11/28 | 1,143 | 1,145 | 1,105 | 1,109 | -34 | -3% | 592,500 |
2017/11/27 | 1,122 | 1,154 | 1,114 | 1,143 | +34 | +3.1% | 500,900 |
2017/11/24 | 1,130 | 1,140 | 1,108 | 1,109 | -18 | -1.6% | 421,100 |
2017/11/22 | 1,122 | 1,165 | 1,117 | 1,127 | +11 | +1% | 551,900 |
2017/11/21 | 1,105 | 1,129 | 1,091 | 1,116 | +13 | +1.2% | 443,200 |
2017/11/20 | 1,100 | 1,130 | 1,088 | 1,103 | -9 | -0.8% | 471,200 |
2017/11/17 | 1,100 | 1,125 | 1,087 | 1,112 | +12 | +1.1% | 592,600 |
2017/11/16 | 1,038 | 1,100 | 1,035 | 1,100 | +45 | +4.3% | 496,100 |
2017/11/15 | 1,094 | 1,099 | 1,034 | 1,055 | -36 | -3.3% | 787,900 |
2017/11/14 | 1,112 | 1,130 | 1,081 | 1,091 | -30 | -2.7% | 525,800 |
2017/11/13 | 1,140 | 1,203 | 1,112 | 1,121 | +7 | +0.6% | 852,600 |
2017/11/10 | 1,086 | 1,141 | 1,080 | 1,114 | +3 | +0.3% | 516,200 |
1851~
1900
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム